Clinical Trials Browser

Recurrence × Rituximab × Head & Neck × Clear all

NCT04361409 2020-04-28

Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence